| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1051734988 |
| P356 | DOI | 10.1038/SREP06446 |
| P932 | PMC publication ID | 4192636 |
| P698 | PubMed publication ID | 25300247 |
| P5875 | ResearchGate publication ID | 266745156 |
| P50 | author | Firas Kobeissy | Q56989716 |
| Stefania Mondello | Q47504595 | ||
| P2093 | author name string | David Wilson | |
| Jeff Randall | |||
| Andreas Jeromin | |||
| David Hanlon | |||
| Andras Buki | |||
| Pal Barzo | |||
| Gail Provuncher | |||
| P2860 | cites work | Prevalence and impact of diffuse axonal injury in patients with moderate and severe head injury: a cohort study of early magnetic resonance imaging findings and 1-year outcome | Q48426042 |
| βA4 amyloid protein deposition in brain after head trauma | Q48611315 | ||
| Plasma β-amyloid levels in cerebral amyloid angiopathy-associated hemorrhagic stroke. | Q48702297 | ||
| Amyloid beta protein 1-40 and 1-42 levels in matched cerebrospinal fluid and plasma from patients with Alzheimer disease | Q48891427 | ||
| Standardization of measurement of beta-amyloid(1-42) in cerebrospinal fluid and plasma | Q49069882 | ||
| Monitoring of β-amyloid dynamics after human traumatic brain injury. | Q50856433 | ||
| Marked increase of beta-amyloid(1-42) and amyloid precursor protein in ventricular cerebrospinal fluid after severe traumatic brain injury. | Q53263063 | ||
| Amyloid beta 1-42 and tau in cerebrospinal fluid after severe traumatic brain injury | Q73385164 | ||
| The spectrum of disease in chronic traumatic encephalopathy | Q22242925 | ||
| Amyloid plaque core protein in Alzheimer disease and Down syndrome | Q24568384 | ||
| A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β. | Q24631193 | ||
| Hypoxia due to cardiac arrest induces a time-dependent increase in serum amyloid β levels in humans | Q28741472 | ||
| Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade | Q29614407 | ||
| Dementia resulting from traumatic brain injury: what is the pathology? | Q34032721 | ||
| Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations | Q34056386 | ||
| Cerebrospinal fluid and plasma biomarkers in Alzheimer disease | Q34098866 | ||
| New perspectives on amyloid-beta dynamics after acute brain injury: moving between experimental approaches and studies in the human brain | Q34137762 | ||
| Evaluation of plasma Abeta(40) and Abeta(42) as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment | Q34779254 | ||
| Neuronal and glial markers are differently associated with computed tomography findings and outcome in patients with severe traumatic brain injury: a case control study | Q35558386 | ||
| Blood-brain barrier breakdown as a therapeutic target in traumatic brain injury | Q36763899 | ||
| Amyloid-β Peptides and Tau Protein as Biomarkers in Cerebrospinal and Interstitial Fluid Following Traumatic Brain Injury: A Review of Experimental and Clinical Studies | Q36955963 | ||
| Long-term consequences of repetitive brain trauma: chronic traumatic encephalopathy | Q37950574 | ||
| Amyloid-beta dynamics correlate with neurological status in the injured human brain | Q42241419 | ||
| Prognostic value of plasma β-amyloid levels in patients with acute intracerebral hemorrhage. | Q44979336 | ||
| Monitoring of brain interstitial total tau and beta amyloid proteins by microdialysis in patients with traumatic brain injury | Q46122385 | ||
| α-Synuclein in CSF of patients with severe traumatic brain injury | Q48098403 | ||
| Alterations in cerebrospinal fluid apolipoprotein E and amyloid beta-protein after traumatic brain injury. | Q48158131 | ||
| Correlation of computed tomography findings and serum brain damage markers following severe head injury | Q48353642 | ||
| CSF Abeta 42 levels correlate with amyloid-neuropathology in a population-based autopsy study | Q48381623 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International | Q24082749 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | traumatic brain injury | Q1995526 |
| P304 | page(s) | 6446 | |
| P577 | publication date | 2014-10-10 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | CSF and plasma amyloid-β temporal profiles and relationships with neurological status and mortality after severe traumatic brain injury | |
| P478 | volume | 4 |
| Q37494841 | Active duty service members who sustain a traumatic brain injury have chronically elevated peripheral concentrations of Aβ40 and lower ratios of Aβ42/40. |
| Q41518367 | Analytical performance of reagent for assaying tau protein in human plasma and feasibility study screening neurodegenerative diseases |
| Q39061827 | Biomarkers of Traumatic Brain Injury: Temporal Changes in Body Fluids |
| Q48634231 | Blood biomarkers indicate mild neuroaxonal injury and increased amyloid β production after transient hypoxia during breath-hold diving |
| Q48663991 | Cerebral Hypoperfusion and the Energy Deficit in Alzheimer's Disease |
| Q26771852 | Cerebrovascular disease in ageing and Alzheimer's disease |
| Q64106621 | Comparative analyses of plasma amyloid-β levels in heterogeneous and monomerized states by interdigitated microelectrode sensor system |
| Q47133242 | Current Opportunities for Clinical Monitoring of Axonal Pathology in Traumatic Brain Injury |
| Q41598901 | Current and Emerging Technologies for Probing Molecular Signatures of Traumatic Brain Injury |
| Q39451605 | Detection of Plasma Biomarkers Using Immunomagnetic Reduction: A Promising Method for the Early Diagnosis of Alzheimer's Disease |
| Q48264365 | Elevated serum miR-93, miR-191, and miR-499 are noninvasive biomarkers for the presence and progression of traumatic brain injury |
| Q57764732 | Finding effective biomarkers for pediatric traumatic brain injury |
| Q28066813 | Fluid Biomarkers of Traumatic Brain Injury and Intended Context of Use |
| Q48671537 | Increases of Plasma Levels of Glial Fibrillary Acidic Protein, Tau, and Amyloid β up to 90 Days after Traumatic Brain Injury |
| Q47109309 | Inflammation Relates to Chronic Behavioral and Neurological Symptoms in Military Personnel with Traumatic Brain Injuries |
| Q58596203 | Integration of Biomarkers Into a Signature Profile of Persistent Traumatic Brain Injury Involving Autoimmune Processes Following Water Hammer Injury From Repetitive Head Impacts |
| Q55432318 | MicroRNA Signature of Traumatic Brain Injury: From the Biomarker Discovery to the Point-of-Care. |
| Q59844906 | Military-related risk factors for dementia |
| Q48295269 | Moderate blast exposure results in increased IL-6 and TNFα in peripheral blood. |
| Q37169574 | Pathophysiology of Hypoperfusion of the Precuneus in Early Alzheimer's Disease |
| Q38793329 | Physical activity predicts reduced plasma β amyloid in the Cardiovascular Health Study |
| Q46359161 | Rapid amyloid-β oligomer and protofibril accumulation in traumatic brain injury |
| Q37019440 | Serum Concentrations of Ubiquitin C-Terminal Hydrolase-L1 and Glial Fibrillary Acidic Protein after Pediatric Traumatic Brain Injury |
| Q26753059 | Traumatic Axonal Injury: Mechanisms and Translational Opportunities |
| Q40507322 | sAβPPα is a Potent Endogenous Inhibitor of BACE1. |
Search more.